文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

自发性纵隔气肿:重症COVID-19患者中P-SILI的替代标志物

Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients.
PubMed 文献 · Crit Care · 2022-11-12
一句话结论重症COVID-19无创呼吸支持期间自发性纵隔气肿(SP)发生率为4%,SP患者气管插管时间更长(6天 vs 2天,P=0.00002),可能提示P-SILI。

这项回顾性多中心观察性研究纳入549例重症COVID-19肺炎患者,旨在描述未接受有创机械通气(IMV)前自发性纵隔气肿(SP)的患病率与结局,以排除IMV在纵隔气肿发生中的机制。21例(4%)在接受无创呼吸支持期间发生SP,距ICU入住中位时间6天[4-12]。SP患者需要IMV的比例相似,但气管插管时间更长(6天[5-13] vs 2天[1-4],P=0.00002),一线使用无创通气比例更高(52% vs 28%,P=0.02)。SP患者ICU入住至SP发生期间持续存在严重肺病和呼吸衰竭征象,ROX指数更低(入ICU时3.94[3.15-5.55] vs SP前一日3.25[2.73-4.02],P=0.1),可能提示患者自身肺损伤(P-SILI)。

要点

  • 549例重症COVID-19肺炎患者中21例(4%)在无创呼吸支持期间发生SP,距ICU入住中位6天[4-12]。
  • SP患者气管插管时间更长:6天[5-13] vs 2天[1-4],P=0.00002。
  • SP患者一线使用无创通气比例更高:52%(11例)vs 28%(150例),P=0.02。
  • SP患者ROX指数从入ICU时3.94[3.15-5.55]降至SP前一日3.25[2.73-4.02],P=0.1,可能提示P-SILI。
  • SP患者更常使用血管升压药,ICU住院时间更长。

适用人群与场景

  • 重症COVID-19肺炎、接受无创呼吸支持(未接受有创机械通气)的危重症患者。
  • 回顾性多中心观察性研究,共549例患者。

研究设计与关键结果

  • 研究类型:回顾性多中心观察性研究,纳入549例重症COVID-19肺炎患者。
  • 21例(4%)在接受无创呼吸支持期间发生SP,距ICU入住中位6天[4-12]。
  • SP患者需要IMV的比例与无SP患者相似。
  • SP患者气管插管时间更长:6天[5-13] vs 2天[1-4],P=0.00002。
  • SP患者一线使用无创通气比例更高:52%(n=11)vs 28%(n=150),P=0.02。
  • SP患者ROX指数:入ICU时3.94[3.15-5.55] vs SP前一日3.25[2.73-4.02],P=0.1。
  • SP患者更常使用血管升压药,ICU住院时间更长。

证据类型、等级与局限

  • 证据类型:回顾性多中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,SP可能由与呼吸衰竭延长相关的P-SILI机制所致,依据为IMV延迟使用及ROX指数从ICU入住至SP前一日的变化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Spontaneous pneumomediastinum (SP) has been described early during the COVID-19 pandemic in large series of patients with severe pneumonia, but most patients were receiving invasive mechanical ventilation (IMV) at the time of SP diagnosis. In this retrospective multicenter observational study, we aimed at describing the prevalence and outcomes of SP during severe COVID-19 with pneumonia before any IMV, to rule out mechanisms induced by IMV in the development of pneumomediastinum.Among 549 patients, 21 patients (4%) developed a SP while receiving non-invasive respiratory support, after a median of 6 days [4-12] from ICU admission. The proportion of patients requiring IMV was similar. However, the time to tracheal intubation was longer in patients with SP (6 days [5-13] vs. 2 days [1-4]; P = 0.00002), with a higher first-line use of non-invasive ventilation (n = 11; 52% vs. n = 150; 28%; P = 0.02). The 21 patients who developed a SP had persisting signs of severe lung disease and respiratory failure with lower ROX index between ICU admission and occurrence of SP (3.94 [3.15-5.55] at admission vs. 3.25 [2.73-4.02] the day preceding SP; P = 0.1), which may underline potential indirect signals of Patient-self inflicted lung injury (P-SILI).In this series of critically ill COVID-19 patients, the prevalence of SP without IMV was not uncommon, affecting 4% of patients. They received more often vasopressors and had a longer ICU length of stay, as compared with their counterparts. One pathophysiological mechanism may potentially be carried out by P-SILI related to a prolonged respiratory failure, as underlined by a delayed use of IMV and the evolution of the ROX index between ICU admission and the day preceding SP.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Elabbadi A, Urbina T, Berti E, et al. Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients. Crit Care. 2022. PMID: 36371306. doi:10.1186/s13054-022-04228-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。